The reason why the SP is at .05 is because these clowns are actually serious about building a sustainable business.
In time .. you will see the transition ... EasyDNA was 1st up .. now Mutli-test ... NEXT we have Germline reimbursable Breast / Colorectal coming.
I UNDERSTAND the history (different management) and hence can TRULY appreciate the frustration of HOLDERS (including me).
We now have CEO; CFO etc..........; and some medical advisors on board.
Lets not underestimate of THE accountability in getting approval for Multi-test is AUS / US (& Covid test in US) .. something must make sense for AUS/US authorities to approve ?
Yes - for succ a low Cap company ... Risk Vs REward is worth debating.
GLTAH ( and PLEASE DYOR)
- Forums
- ASX - By Stock
- Ann: Genetic Technologies 1H FY22 results
The reason why the SP is at .05 is because these clowns are...
Featured News
Add GTG (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.671M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
GTG (ASX) Chart |
Day chart unavailable
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online